List of Tables
Table 1. Global DTIs for Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global DTIs for Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global DTIs for Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global DTIs for Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global DTIs for Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global DTIs for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global DTIs for Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market DTIs for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of DTIs for Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of DTIs for Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of DTIs for Injection, Product Types and Applications
Table 12. Global Key Manufacturers of DTIs for Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DTIs for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on DTIs for Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DTIs for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global DTIs for Injection Sales by Region (K Units), 2021–2026
Table 18. Global DTIs for Injection Sales Market Share by Region (2021–2026)
Table 19. Global DTIs for Injection Sales by Region (K Units), 2027–2032
Table 20. Global DTIs for Injection Sales Market Share by Region (2027–2032)
Table 21. Global DTIs for Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global DTIs for Injection Revenue Market Share by Region (2021–2026)
Table 23. Global DTIs for Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global DTIs for Injection Revenue Market Share by Region (2027–2032)
Table 25. North America DTIs for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America DTIs for Injection Sales by Country (K Units), 2021–2026
Table 27. North America DTIs for Injection Sales by Country (K Units), 2027–2032
Table 28. North America DTIs for Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America DTIs for Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe DTIs for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe DTIs for Injection Sales by Country (K Units), 2021–2026
Table 32. Europe DTIs for Injection Sales by Country (K Units), 2027–2032
Table 33. Europe DTIs for Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe DTIs for Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific DTIs for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific DTIs for Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific DTIs for Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific DTIs for Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific DTIs for Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America DTIs for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America DTIs for Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America DTIs for Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America DTIs for Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America DTIs for Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa DTIs for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa DTIs for Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa DTIs for Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa DTIs for Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa DTIs for Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global DTIs for Injection Sales (K Units) by Type (2021–2026)
Table 51. Global DTIs for Injection Sales (K Units) by Type (2027–2032)
Table 52. Global DTIs for Injection Sales Market Share by Type (2021–2026)
Table 53. Global DTIs for Injection Sales Market Share by Type (2027–2032)
Table 54. Global DTIs for Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global DTIs for Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global DTIs for Injection Revenue Market Share by Type (2021–2026)
Table 57. Global DTIs for Injection Revenue Market Share by Type (2027–2032)
Table 58. Global DTIs for Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global DTIs for Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global DTIs for Injection Sales (K Units) by Application (2021–2026)
Table 61. Global DTIs for Injection Sales (K Units) by Application (2027–2032)
Table 62. Global DTIs for Injection Sales Market Share by Application (2021–2026)
Table 63. Global DTIs for Injection Sales Market Share by Application (2027–2032)
Table 64. Global DTIs for Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global DTIs for Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global DTIs for Injection Revenue Market Share by Application (2021–2026)
Table 67. Global DTIs for Injection Revenue Market Share by Application (2027–2032)
Table 68. Global DTIs for Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global DTIs for Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Mitsubishi Tanabe Pharma Company Information
Table 71. Mitsubishi Tanabe Pharma Description and Business Overview
Table 72. Mitsubishi Tanabe Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Mitsubishi Tanabe Pharma DTIs for Injection Product
Table 74. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer DTIs for Injection Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Sandoz Company Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sandoz DTIs for Injection Product
Table 84. Sandoz Recent Developments/Updates
Table 85. The Medicines Company Company Information
Table 86. The Medicines Company Description and Business Overview
Table 87. The Medicines Company DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. The Medicines Company DTIs for Injection Product
Table 89. The Medicines Company Recent Developments/Updates
Table 90. Accord Healthcare Company Information
Table 91. Accord Healthcare Description and Business Overview
Table 92. Accord Healthcare DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Accord Healthcare DTIs for Injection Product
Table 94. Accord Healthcare Recent Developments/Updates
Table 95. Apotex Company Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Apotex DTIs for Injection Product
Table 99. Apotex Recent Developments/Updates
Table 100. Aurobindo Pharma Company Information
Table 101. Aurobindo Pharma Description and Business Overview
Table 102. Aurobindo Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Aurobindo Pharma DTIs for Injection Product
Table 104. Aurobindo Pharma Recent Developments/Updates
Table 105. GlaxoSmithKline Company Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. GlaxoSmithKline DTIs for Injection Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Teva Pharmaceutical Company Information
Table 111. Teva Pharmaceutical Description and Business Overview
Table 112. Teva Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Teva Pharmaceutical DTIs for Injection Product
Table 114. Teva Pharmaceutical Recent Developments/Updates
Table 115. Eugia Pharma Company Information
Table 116. Eugia Pharma Description and Business Overview
Table 117. Eugia Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Eugia Pharma DTIs for Injection Product
Table 119. Eugia Pharma Recent Developments/Updates
Table 120. Dr.Reddy's Laboratories Company Information
Table 121. Dr.Reddy's Laboratories Description and Business Overview
Table 122. Dr.Reddy's Laboratories DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Dr.Reddy's Laboratories DTIs for Injection Product
Table 124. Dr.Reddy's Laboratories Recent Developments/Updates
Table 125. Yangtze River Pharmaceutical Company Information
Table 126. Yangtze River Pharmaceutical Description and Business Overview
Table 127. Yangtze River Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Yangtze River Pharmaceutical DTIs for Injection Product
Table 129. Yangtze River Pharmaceutical Recent Developments/Updates
Table 130. BrightGene Company Information
Table 131. BrightGene Description and Business Overview
Table 132. BrightGene DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. BrightGene DTIs for Injection Product
Table 134. BrightGene Recent Developments/Updates
Table 135. Lunan Pharmaceutical Company Information
Table 136. Lunan Pharmaceutical Description and Business Overview
Table 137. Lunan Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Lunan Pharmaceutical DTIs for Injection Product
Table 139. Lunan Pharmaceutical Recent Developments/Updates
Table 140. CSPC Ouyi Pharmaceutical Company Information
Table 141. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 142. CSPC Ouyi Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. CSPC Ouyi Pharmaceutical DTIs for Injection Product
Table 144. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 145. Beijing SL Pharmaceutical Company Information
Table 146. Beijing SL Pharmaceutical Description and Business Overview
Table 147. Beijing SL Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Beijing SL Pharmaceutical DTIs for Injection Product
Table 149. Beijing SL Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. DTIs for Injection Distributors List
Table 153. DTIs for Injection Customers List
Table 154. DTIs for Injection Market Trends
Table 155. DTIs for Injection Market Drivers
Table 156. DTIs for Injection Market Challenges
Table 157. DTIs for Injection Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of DTIs for Injection
Figure 2. Global DTIs for Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global DTIs for Injection Market Share by Type: 2025 & 2032
Figure 4. Argatroban Product Picture
Figure 5. Bivalirudin Product Picture
Figure 6. Other Product Picture
Figure 7. Global DTIs for Injection Market Value by Application (US$ Million), 2021–2032
Figure 8. Global DTIs for Injection Market Share by Application: 2025 & 2032
Figure 9. Deep Vein Thrombosis
Figure 10. Pulmonary Embolism
Figure 11. Atrial Fibrillation
Figure 12. Other
Figure 13. Global DTIs for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global DTIs for Injection Market Size (US$ Million), 2021–2032
Figure 15. Global DTIs for Injection Sales (K Units), 2021–2032
Figure 16. Global DTIs for Injection Average Price (US$/Unit), 2021–2032
Figure 17. DTIs for Injection Report Years Considered
Figure 18. DTIs for Injection Sales Share by Manufacturers in 2025
Figure 19. Global DTIs for Injection Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global DTIs for Injection Players: Market Share by Revenue in DTIs for Injection in 2025
Figure 21. DTIs for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global DTIs for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America DTIs for Injection Sales Market Share by Country (2021–2032)
Figure 24. North America DTIs for Injection Revenue Market Share by Country (2021–2032)
Figure 25. United States DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe DTIs for Injection Sales Market Share by Country (2021–2032)
Figure 28. Europe DTIs for Injection Revenue Market Share by Country (2021–2032)
Figure 29. Germany DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific DTIs for Injection Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific DTIs for Injection Revenue Market Share by Region (2021–2032)
Figure 36. China DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America DTIs for Injection Sales Market Share by Country (2021–2032)
Figure 44. Latin America DTIs for Injection Revenue Market Share by Country (2021–2032)
Figure 45. Mexico DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa DTIs for Injection Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa DTIs for Injection Revenue Market Share by Country (2021–2032)
Figure 51. Turkey DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE DTIs for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of DTIs for Injection by Type (2021–2032)
Figure 55. Global Revenue Market Share of DTIs for Injection by Type (2021–2032)
Figure 56. Global DTIs for Injection Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of DTIs for Injection by Application (2021–2032)
Figure 58. Global Revenue Market Share of DTIs for Injection by Application (2021–2032)
Figure 59. Global DTIs for Injection Price (US$/Unit) by Application (2021–2032)
Figure 60. DTIs for Injection Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
